Concepedia

Marieke Biegstraaten

MB

Statistics

Publications

20

Citations

1.8K

H-Index

16

Active since

2010

Affiliations

Amsterdam UMC Location University of Amsterdam(Current)

University College London

University of Amsterdam

Royal Free London NHS Foundation Trust

The Royal Free Hospital

Marieke Biegstraaten is an author at Amsterdam UMC Location University of Amsterdam specializing in fabry disease, medicine, and enzyme replacement therapy.

Publications per year

2010–2018

20

Publications

20

Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study

Maarten Arends, Christoph Wanner, Derralynn Hughes et al. · Journal of the American Society of Nephrology · 2016 · 421 citations · Full text

, , +9

Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document

Marieke Biegstraaten, Reynir Arngrı́msson, Frédéric Barbey et al. · Orphanet Journal of Rare Diseases · 2015 · 345 citations · Full text

, , +13

Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease

Bouwien E. Smid, Linda van der Tol, Marieke Biegstraaten et al. · Journal of Medical Genetics · 2015 · 163 citations · Full text

, , +13

Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study

Maarten Arends, Marieke Biegstraaten, Christoph Wanner et al. · Journal of Medical Genetics · 2018 · 125 citations · Full text

, , +14

Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors

Maarten Arends, Marieke Biegstraaten, Derralynn Hughes et al. · PLoS ONE · 2017 · 109 citations · Full text

, , +17

1–5 of 20